Patients with infective endocarditis undergoing cardiac surgery have distinct ROTEM profiles and more bleeding complications compared to patients without infective endocarditis
Abstract:Background
The coagulation system is crucial in the pathogenesis of infective endocarditis and undergoes significant changes during course of the disease. However, little is known about the implications of those changes in the perioperative period. Aim of the present study was to delineate the specific coagulation patterns and their clinical consequence in patients undergoing cardiac surgery due to infective endocarditis.
Methods
In this single-centre, exploratory, prospective observational study, we investi… Show more
“…Different 'hypocoagulable' profiles evaluated by pointof-care hemostatic devices in other settings of diseases and conditions had been considered to consist valuable predictors of poor outcome in critically ill patients [36,37].…”
Background
Global coagulation tests offer a better tool to assess procoagulant and anticoagulant pathways, fibrinolysis and clot firmness and evaluate more accurately coagulation defects compared to conventional coagulation tests. Their prognostic role in acute-on-chronic liver disease (ACLF) or acute decompensation (AD) has not been well established.
Aims
To assess the properties and prognostic value of the coagulation profile measured by rotational thromboelastometry (ROTEM) in ACLF and AD.
Methods
84 consecutive patients (35 ACLF and 49 AD) were prospectively studied. Twenty healthy persons matched for age and gender were used as controls. ‘Hypocoagulable’ or ‘hypercoagulable’ profiles on admission were assessed based on nine ROTEM parameters and mortality was recorded at 30 and 90 days.
Results
Individual ROTEM parameters denoted significantly more hypocoagulability in patients compared to controls. ‘Hypocoagulable’ profile (defined as a composite of 4 or more ROTEM parameters outside the range) was associated with more severe liver disease assessed either as MELD or Child-Pugh scores (P < 0.001 for both) and higher 30-day mortality (Log-rank P = 0.012). ‘Hypocoagulable’ profile (HR 3.160, 95% CI 1.003–9.957, P = 0.049) and ACLF status (HR 23.786, 95% CI 3.115–181.614, P = 0.002) were independent predictors of 30-day mortality, in multivariate model. A higher early mortality rate was shown in ACLF patients with ‘hypocoagulable’ phenotype compared to those without (Log-rank P = 0.017). ‘Hypocoagulable’ profile was not associated with mortality in AD.
Conclusion
‘Hypocoagulable’ profile was associated with more advanced liver disease and higher short-term mortality in patients with ACLF.
“…Different 'hypocoagulable' profiles evaluated by pointof-care hemostatic devices in other settings of diseases and conditions had been considered to consist valuable predictors of poor outcome in critically ill patients [36,37].…”
Background
Global coagulation tests offer a better tool to assess procoagulant and anticoagulant pathways, fibrinolysis and clot firmness and evaluate more accurately coagulation defects compared to conventional coagulation tests. Their prognostic role in acute-on-chronic liver disease (ACLF) or acute decompensation (AD) has not been well established.
Aims
To assess the properties and prognostic value of the coagulation profile measured by rotational thromboelastometry (ROTEM) in ACLF and AD.
Methods
84 consecutive patients (35 ACLF and 49 AD) were prospectively studied. Twenty healthy persons matched for age and gender were used as controls. ‘Hypocoagulable’ or ‘hypercoagulable’ profiles on admission were assessed based on nine ROTEM parameters and mortality was recorded at 30 and 90 days.
Results
Individual ROTEM parameters denoted significantly more hypocoagulability in patients compared to controls. ‘Hypocoagulable’ profile (defined as a composite of 4 or more ROTEM parameters outside the range) was associated with more severe liver disease assessed either as MELD or Child-Pugh scores (P < 0.001 for both) and higher 30-day mortality (Log-rank P = 0.012). ‘Hypocoagulable’ profile (HR 3.160, 95% CI 1.003–9.957, P = 0.049) and ACLF status (HR 23.786, 95% CI 3.115–181.614, P = 0.002) were independent predictors of 30-day mortality, in multivariate model. A higher early mortality rate was shown in ACLF patients with ‘hypocoagulable’ phenotype compared to those without (Log-rank P = 0.017). ‘Hypocoagulable’ profile was not associated with mortality in AD.
Conclusion
‘Hypocoagulable’ profile was associated with more advanced liver disease and higher short-term mortality in patients with ACLF.
“…Furthermore, it is not entirely clear whether cardiac surgery for IE is per se associated with an increased risk of bleeding. While the transfusion rate is indeed higher in IE [79], after correction for risk factors such as age, sex, BMI, or anemia, IE was not independently associated with blood transfusion [84]. The incidence of DIC is between 1and 20%, and the occurrence of DIC is associated with increased mortality [12,85].…”
Section: Coagulopathy and Bleedingmentioning
confidence: 95%
“…However, during cardiac surgery for IE, the occurrence of severe coagulopathy and bleeding is common. Intraoperative coagulopathy and bleeding in IE can result from various factors, including the patient's underlying coagulation status, the use of anticoagulant agents, surgical trauma, and infection-related factors such as platelet dysfunction and disseminated intravascular coagulation (DIC) [79,80]. Furthermore, many antibiotics that are used to treat IE can affect coagulation, either by direct interaction with the coagulation system or via drug-drug interaction, such as, e.g., between cefazoline and vitamin k antagonists [3].…”
Infective endocarditis is a challenging condition to manage, requiring collaboration among various medical professionals. Interdisciplinary teamwork within endocarditis teams is essential. About half of the patients diagnosed with the disease will ultimately have to undergo cardiac surgery. As a result, it is vital for all healthcare providers involved in the perioperative period to have a comprehensive understanding of the unique features of infective endocarditis, including clinical presentation, echocardiographic signs, coagulopathy, bleeding control, and treatment of possible organ dysfunction. This narrative review provides a summary of the current knowledge on the incidence of complications and their management in the perioperative period in patients with infective endocarditis.
“…A preoperative lower fibrinogen (Huang et al, 2019) and a greater loss of fibrinogen during surgery, with decreased firmness of blood clots, was associated with an increased need for transfusion (Huang et al, 2019). Apart from preoperative coagulopathy, anemia and renal failure associated with IE were also held accountable for transfusion need (Breel et al, 2023;Huang et al, 2019). The best predictor for the transfusion of RBC was preoperative hemoglobin level (de Boer et al, 2016).…”
Section: Endocarditis Complexity Of Surgery and Coagulationmentioning
confidence: 99%
“…In six series of varying size, IE itself led to hemostatic problems leading to an increased need for transfusion (Breel et al, 2023;Czerwinska-Jelonkiewicz et al, 2023;de Boer et al, 2016), especially with active IE (Huang et al, 2019), prosthetic valve IE (Salem et al, 2021) or when coagulase negative staphylococcus aureus was involved (Polzin et al, 2022). In one report, IE itself had no effect but its potential consequence, the need for complex aortic valve surgery was associated with this increased need for transfusion.…”
Section: Effect Of Ie On Transfusion Needsmentioning
Infective Endocarditis (IE) is a serious condition with a high mortality rate, even after surgery. Need for transfusion might be increased in surgery for IE. This review aims to identify the predictors for the need of transfusion in IE patients and the effect of transfusion on outcome. Only 17 manuscripts could be identified partially addressing this issue. Minimal access surgery and valve repair instead of replacement seems favorable in this respect. However, IE has opposing effects on the coagulation system with increase in bleeding and thromboembolic events. There are indications that in IE patients, transfusion need is higher but this might be compounded by the complexity of surgery and a prolonged cardiopulmonary bypass (CPB) time. Since organ dysfunction is associated with IE, this comorbidity could cloud the effect of the need for transfusion on outcome. To avoid potential adverse effect of transfusion, alternative methods have been proposed such as the use of cytokine absorbers during CPB run, intraoperative cell salvage and acute normovolemic hemodilution. These methods need further study in this subgroup of patients. In the meantime, allogeneic transfusion should be kept at a minimum, using only recently stored blood, to minimize harmful effects.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.